PT93877A - Processo para a preparacao de composicoes farmaceuticas para administracao oral de medicamentos, por exemplo antibioticos beta-lactamicos - Google Patents

Processo para a preparacao de composicoes farmaceuticas para administracao oral de medicamentos, por exemplo antibioticos beta-lactamicos

Info

Publication number
PT93877A
PT93877A PT93877A PT9387790A PT93877A PT 93877 A PT93877 A PT 93877A PT 93877 A PT93877 A PT 93877A PT 9387790 A PT9387790 A PT 9387790A PT 93877 A PT93877 A PT 93877A
Authority
PT
Portugal
Prior art keywords
medicines
preparation
pharmaceutical compositions
oral administration
example beta
Prior art date
Application number
PT93877A
Other languages
English (en)
Other versions
PT93877B (pt
Inventor
David Roy Merrifield
Paul Laurence Carter
Ian James Bolt
Original Assignee
Beecham Group Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group Plc filed Critical Beecham Group Plc
Publication of PT93877A publication Critical patent/PT93877A/pt
Publication of PT93877B publication Critical patent/PT93877B/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
PT93877A 1989-04-28 1990-04-26 Processo para a preparacao de composicoes farmaceuticas para administracao oral de medicamentos, por exemplo antibioticos beta-lactamicos PT93877B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898909793A GB8909793D0 (en) 1989-04-28 1989-04-28 Pharmaceutical formulation

Publications (2)

Publication Number Publication Date
PT93877A true PT93877A (pt) 1990-11-20
PT93877B PT93877B (pt) 1996-09-30

Family

ID=10655920

Family Applications (1)

Application Number Title Priority Date Filing Date
PT93877A PT93877B (pt) 1989-04-28 1990-04-26 Processo para a preparacao de composicoes farmaceuticas para administracao oral de medicamentos, por exemplo antibioticos beta-lactamicos

Country Status (17)

Country Link
US (2) US5225197A (pt)
EP (1) EP0396335B1 (pt)
JP (1) JP2992761B2 (pt)
KR (1) KR0167554B1 (pt)
AT (1) ATE101034T1 (pt)
AU (1) AU627298B2 (pt)
CA (1) CA2015536C (pt)
CY (1) CY1957A (pt)
DE (1) DE69006385T2 (pt)
DK (1) DK0396335T3 (pt)
ES (1) ES2062353T3 (pt)
GB (1) GB8909793D0 (pt)
HK (1) HK1004522A1 (pt)
IE (1) IE63806B1 (pt)
NZ (1) NZ233441A (pt)
PT (1) PT93877B (pt)
ZA (1) ZA903181B (pt)

Families Citing this family (95)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2633181B1 (fr) * 1988-06-24 1992-01-10 Glaxo Lab Sa Composition pharmaceutique a base de ranitidine et son procede de preparation
US5178878A (en) * 1989-10-02 1993-01-12 Cima Labs, Inc. Effervescent dosage form with microparticles
ATE145551T1 (de) * 1989-10-02 1996-12-15 Cima Labs Inc Brausedosisform sowie verfahren zu deren verabreichung
US5223264A (en) * 1989-10-02 1993-06-29 Cima Labs, Inc. Pediatric effervescent dosage form
US5064656A (en) * 1989-11-14 1991-11-12 Dr. Gergely & Co. Uncoated pharmaceutical reaction tablet
US5744500A (en) * 1990-01-03 1998-04-28 Teva Pharmaceutical Industries, Ltd. Use of R-enantiomer of N-propargyl-1-aminoindan, salts, and compositions thereof
US5814337A (en) * 1992-10-07 1998-09-29 Beecham Group Plc Pharmaceutical formulation
US5670170A (en) * 1990-04-27 1997-09-23 Beecham Group P.L.C. Pharamaceutical formulation
GB9009473D0 (en) 1990-04-27 1990-06-20 Beecham Group Plc Pharmaceutical formulation
US5468504A (en) * 1990-12-21 1995-11-21 Laboratoires Glaxo S.A. Effervescent pharmaceutical compositions
GB9027827D0 (en) * 1990-12-21 1991-02-13 Glaxo Laboratoires Pharmaceutical compositions
CA2106216C (en) * 1991-04-04 1997-06-10 Paul Randolph Court Chewable antacid compositions
GB9108128D0 (en) * 1991-04-15 1991-06-05 Zambeletti Spa L Novel formulation
EP0574624B1 (en) * 1992-06-17 1997-09-10 Laboratoires Glaxo Sa Pharmaceutical compositions
US5330760A (en) * 1992-08-27 1994-07-19 Sterling Winthrop Inc. Effervescent antacid
NZ250363A (en) * 1992-12-04 1996-11-26 Susanna Elizabeth Chalmers A topical dressing containing a dessicant and an antimicrobial or antiseptic agent
HU217125B (hu) * 1993-03-10 1999-11-29 Béres Rt. Cukor- és nátriummentes pezsgőtabletta és -granulátum és eljárás azok előállítására
WO1995005165A1 (en) * 1993-08-13 1995-02-23 Bayer Corporation Hydrolyzed gelatin as a flavor enhancer in a chewable tablet
US5622980A (en) * 1993-08-17 1997-04-22 Applied Analytical Industries, Inc. Oral compositions of H2-antagonists
FR2709420B1 (fr) * 1993-09-01 1995-11-17 Sogeval Comprimé vétérinaire plus spécialement destiné aux chats.
FI103442B (fi) * 1993-09-24 1999-06-30 Nokia Telecommunications Oy Digitaalinen radiolinkkijärjestelmä ja radiolinkkilaite
IL112779A (en) * 1994-03-01 1999-11-30 Gergely Gerhard Granular product or tablet containing an efferescent system and an active pharmaceutical substance and its preparation
US5399356A (en) * 1994-03-24 1995-03-21 The Procter & Gamble Company Process for making solid dose forms containing bismuth
US5637313A (en) * 1994-12-16 1997-06-10 Watson Laboratories, Inc. Chewable dosage forms
US5639475A (en) * 1995-02-03 1997-06-17 Eurand America, Incorporated Effervescent microcapsules
FR2732217B1 (fr) * 1995-03-29 1997-06-06 Hesnard Xavier Forme d'administration solide a usage oral
AU2814995A (en) * 1995-05-26 1996-12-11 Angelo A. Caputo Chewing gum with fluoride and citric acid
US20030109503A1 (en) * 1995-06-06 2003-06-12 Smithkline Beecham P.L.C. Pharmaceutical formulations comprising clavulanic acid alone or in combination with other beta-lactam antibiotics
TW442287B (en) * 1995-06-13 2001-06-23 American Home Produits Corp Organoleptically acceptable oral pharmaceutical composition comprising the S(+)1,8-diethyl-1-1,3,4,9-tetrahydropyrano[3,4-b] indole-1-acetic acid (Etodolac)
SK74396A3 (en) * 1995-06-13 1997-04-09 American Home Prod Organoleptically acceptable oral pharmaceutical compositions
EP1093812A3 (en) * 1995-09-07 2001-06-06 SmithKline Beecham Corporation Amoxycillin and clavulanate containing pharmaceutical formulation
IL115357A (en) * 1995-09-20 2000-01-31 Teva Pharma Stable compositions containing N-propargyl-1-aminoindan and polyhydric alcohols
US5807577A (en) * 1995-11-22 1998-09-15 Lab Pharmaceutical Research International Inc. Fast-melt tablet and method of making same
US6699885B2 (en) 1996-01-04 2004-03-02 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and methods of using same
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US6645988B2 (en) 1996-01-04 2003-11-11 Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
AT407701B (de) * 1996-08-12 2001-05-25 Biochemie Gmbh Zur direkttablettierung geeignete mischung, die als wesentliche komponenten amoxicillin-trihydrat und das kaliumsalz der clavulansäure enthält und verfahren zur herstellung dieser mischung
TWI225402B (en) 1996-03-13 2004-12-21 Biochemie Gmbh Auxiliary-free agglomerates
WO1997038679A2 (en) * 1996-04-16 1997-10-23 Novartis Consumer Health S.A. Fast disintegrating oral dosage form
GB9613470D0 (en) 1996-06-27 1996-08-28 Ciba Geigy Ag Small solid oral dosage form
FR2753097A1 (fr) * 1996-09-11 1998-03-13 Barrau Francois Gel aqueux ou hydroalcoolique extemporane a viscosite controlee
US6649186B1 (en) 1996-09-20 2003-11-18 Ethypharm Effervescent granules and methods for their preparation
US6488961B1 (en) 1996-09-20 2002-12-03 Ethypharm, Inc. Effervescent granules and methods for their preparation
US5837286A (en) * 1997-01-15 1998-11-17 Pandya; Harish B. Taste masking for unplatable formulations
US20030124187A1 (en) * 1997-02-14 2003-07-03 Smithkline Beecham Laboratoires Pharmaceutiques, Pharmaceutical formulations comprising amoxycillin and clavulanate
US6024981A (en) 1997-04-16 2000-02-15 Cima Labs Inc. Rapidly dissolving robust dosage form
US6667056B2 (en) 1997-07-23 2003-12-23 Chiesi Farmaceutici S.P.A. Pharmaceutical compositions containing an effervescent acid-base couple
US6673380B2 (en) 1998-11-17 2004-01-06 Mcneil-Ppc, Inc. Fortified confectionery delivery systems and methods of preparation thereof
WO1999043306A1 (en) * 1998-02-26 1999-09-02 Banyu Pharmaceutical Co., Ltd. An orally disintegrating composition and its manufacturing method
US6974590B2 (en) 1998-03-27 2005-12-13 Cima Labs Inc. Sublingual buccal effervescent
US20030091629A1 (en) 1998-03-27 2003-05-15 Cima Labs Inc. Sublingual buccal effervescent
DE19814257A1 (de) 1998-03-31 1999-10-07 Asta Medica Ag Brauseformulierungen
DK1083885T3 (da) 1998-06-11 2007-02-26 Pharmacia & Upjohn Co Llc Delavirdintabletformulering
US6365182B1 (en) 1998-08-12 2002-04-02 Cima Labs Inc. Organoleptically pleasant in-mouth rapidly disintegrable potassium chloride tablet
US6296868B1 (en) * 1998-11-19 2001-10-02 Advanced Technology Pharmaceuticals Corporation Chewable tablets containing mannitol and aspartame
FR2786395A1 (fr) * 1998-12-01 2000-06-02 Virbac Sa Compositions seches solubles en presence d'eau et evitant la reaction de maillard a l'etat sec, leur preparation et leurs applications
US6294199B1 (en) * 1999-04-13 2001-09-25 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising administering amoxycillin
US6878386B1 (en) 1999-04-13 2005-04-12 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate
US7250176B1 (en) * 1999-04-13 2007-07-31 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection
US20020006433A1 (en) * 1999-04-29 2002-01-17 Nigel P. Davidson Pharmaceutical formulations
US6589555B2 (en) 1999-12-29 2003-07-08 Mahendra Pandya Effervescent vitaceutical compositions and related methods
EP1309315B1 (en) * 2000-08-18 2006-06-14 Pharmacia Corporation Rapidly disintegrating oral formulation of valdecoxib
US6756057B2 (en) 2000-10-12 2004-06-29 Beecham Pharmaceuticals (Pte) Limited Amoxicillin and potassium clavulanate dosage form
WO2002030392A2 (en) 2000-10-12 2002-04-18 Beecham Pharmaceuticals (Pte) Limited Formulation containing amoxicillin
WO2002045684A2 (en) * 2000-12-06 2002-06-13 Pharmacia Corporation Rapidly dispersing pharmaceutical composition comprising effervescent agents
US20040006111A1 (en) * 2002-01-25 2004-01-08 Kenneth Widder Transmucosal delivery of proton pump inhibitors
EP1496873B2 (en) 2002-04-25 2011-08-10 Banner Pharmacaps, Inc. Chewable soft capsule
US7189416B2 (en) * 2002-11-23 2007-03-13 Glykon Technologies Group, Llc Method for stable and controlled delivery of (-)-hydroxycitric acid
US20040223921A1 (en) * 2003-05-07 2004-11-11 Rau Allen H. Oral care tablet
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
WO2005021056A1 (en) * 2003-08-21 2005-03-10 Cns, Inc. Effervescent delivery system
US7390503B1 (en) 2003-08-22 2008-06-24 Barr Laboratories, Inc. Ondansetron orally disintegrating tablets
US7282217B1 (en) 2003-08-29 2007-10-16 Kv Pharmaceutical Company Rapidly disintegrable tablets
WO2005051350A2 (en) * 2003-10-28 2005-06-09 Torrent Pharmaceuticals Limited Water dispersible tablet
US20070048375A1 (en) * 2003-12-19 2007-03-01 Wolfgang Wiehl Effervescent preparation of a basic medicinally active substance
DE602004031771D1 (de) 2003-12-31 2011-04-21 Cima Labs Inc Brauseformen von opiaten zur oralen anwendung und verfahren zur verabreichung von oxycodon
US7858121B2 (en) 2003-12-31 2010-12-28 Cima Labs, Inc. Effervescent oral fentanyl dosage form and methods of administering fentanyl
EP1708686B1 (en) 2003-12-31 2011-02-16 Cima Labs Inc. Generally linear effervescent oral fentanyl dosage form and methods of administering
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8815916B2 (en) 2004-05-25 2014-08-26 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
ES2624585T3 (es) * 2004-05-28 2017-07-17 Imaginot Pty Ltd. Sistema de suministro de compuesto terapéutico oral
US8216610B2 (en) 2004-05-28 2012-07-10 Imaginot Pty Ltd. Oral paracetamol formulations
CN1968682A (zh) * 2004-06-18 2007-05-23 株式会社柳韩洋行 包含表面改性的碳酸氢钠的阿莫西林和/或克拉维酸口服分散片组合物
CA2629904C (en) * 2005-11-28 2018-07-10 Imaginot Pty Ltd. Oral therapeutic compound delivery system
US20090004270A1 (en) * 2006-01-06 2009-01-01 Amerilab Technologies, Inc. Method of using guava extract
US7611739B2 (en) * 2006-01-06 2009-11-03 Amerilab Technologies, Inc. Method of using guava extract and composition including guava extract
US20070298078A1 (en) * 2006-06-27 2007-12-27 Harrison Michael D Water Soluble Article for Imparting Dietary Fiber to Bottled Water
US12403095B2 (en) 2008-05-30 2025-09-02 Veloxis Pharmaceuticals, Inc. Stabilized tacrolimus composition
PL2575769T3 (pl) * 2010-02-17 2016-12-30 Stabilizowana kompozycja takrolimusu
EP2649989B1 (en) 2012-04-13 2017-10-18 King Saud University Method for preparing a solid dispersion, solid dispersion obtained thereby and use thereof
US20140371174A1 (en) 2013-06-12 2014-12-18 The Procter & Gamble Company Effervescent Dosage Form
RU2014149581A (ru) 2012-06-12 2016-07-10 Дзе Проктер Энд Гэмбл Компани Шипучая лекарственная форма
JP6253393B2 (ja) * 2013-12-19 2017-12-27 花王株式会社 固形状組成物
EP3860599B1 (en) 2018-10-04 2024-05-15 Adeptio Pharmaceuticals Limited (+)-alpha-dihydrotetrabenazine dosage regimen for treating movement disorders

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1098116A (fr) * 1954-01-07 1955-07-18 Marocaine De Prod Chim Et Agri Procédé de fabrication de glossettes contenant des compositions destinées à l'absorption intratissulaire
US3039922A (en) * 1959-08-17 1962-06-19 Carter Prod Inc Method of administering tablets having decongestant and anti-histaminic activity
FR2294M (fr) * 1962-07-30 1964-01-27 Dausse Lab Composition a base de sorbitol.
GB1113492A (en) * 1964-05-20 1968-05-15 Bristol Myers Co Chewable tablets comprising a penicillin antibiotic
SE369036B (pt) * 1972-06-30 1974-08-05 Astra Laekemedel Ab
US4127645A (en) * 1976-05-21 1978-11-28 Life Savers, Inc. Effervescent tablet and method
US4639368A (en) * 1984-08-23 1987-01-27 Farmacon Research Corporation Chewing gum containing a medicament and taste maskers
IE58110B1 (en) * 1984-10-30 1993-07-14 Elan Corp Plc Controlled release powder and process for its preparation
US4704269A (en) * 1985-06-11 1987-11-03 Hudson Pharmaceutical Corporation Effervescent antacid and analgesic compositions
JPH0830005B2 (ja) * 1985-09-25 1996-03-27 ゲルゲリイ、ゲルハルト 崩壊性錠剤とその製造方法
GB8528195D0 (en) * 1985-11-15 1985-12-18 Boots Co Plc Therapeutic compositions
US4851226A (en) * 1987-11-16 1989-07-25 Mcneil Consumer Products Company Chewable medicament tablet containing means for taste masking
US5178878A (en) * 1989-10-02 1993-01-12 Cima Labs, Inc. Effervescent dosage form with microparticles

Also Published As

Publication number Publication date
KR0167554B1 (ko) 1999-01-15
ZA903181B (en) 1991-06-26
PT93877B (pt) 1996-09-30
IE63806B1 (en) 1995-06-14
DE69006385D1 (de) 1994-03-17
IE901489L (en) 1990-10-28
EP0396335B1 (en) 1994-02-02
EP0396335A1 (en) 1990-11-07
NZ233441A (en) 1992-03-26
ES2062353T3 (es) 1994-12-16
HK1004522A1 (en) 1998-11-27
CY1957A (en) 1990-04-26
AU627298B2 (en) 1992-08-20
ATE101034T1 (de) 1994-02-15
KR900015716A (ko) 1990-11-10
CA2015536A1 (en) 1990-10-28
AU5391490A (en) 1990-11-01
CA2015536C (en) 1999-08-24
US5225197A (en) 1993-07-06
DK0396335T3 (da) 1994-03-07
DE69006385T2 (de) 1994-05-19
JPH02295919A (ja) 1990-12-06
US5962022A (en) 1999-10-05
GB8909793D0 (en) 1989-06-14
JP2992761B2 (ja) 1999-12-20

Similar Documents

Publication Publication Date Title
DK0396335T3 (da) Farmaceutisk præparat
US6406717B2 (en) Rapid-melt semi-solid compositions, methods of making same and methods of using same
IT8619675A0 (it) Formulazioni per la preparazione di farmaci a rilascio prolungato adatte alla somministrazione per via orale.
CA2061917A1 (en) Pediatric effervescent dosage form
NO912001L (no) Buccal tablett med hurtig utlevering.
DK1741426T3 (da) Smelteekstruderede oralt administrerbare hydromorphonformuleringer
HUT55220A (en) Process for producing pharmaceutical composition suitable for systemic administration through the skin and comprising deprenyl as active ingredient
DK0841903T3 (da) Orale farmaceutiske præparater indeholdende antimikrobielt virksomme aktivstoffer og sustained release pantoprazol
ATA195588A (de) Epipodophyllotoxinglucosid-4'-phosphat-derivate deren herstellung, sowie pharmazeutische zusammensetzungen hierzu
DK0421541T3 (da) Tabletstruktur, som kan deles
AU2002364468C1 (en) Solid orally-dispersible pharmaceutical formulation
NZ225242A (en) Pad printing process for manufacturing a pharmaceutical presentation and/or dosage form for active ingredients of drugs
IL159217A0 (en) An oral pharmaceutical formulation comprising a basic pharmaceutically active ingredient having ph-dependent solubility, a process for the manufacture thereof and use thereof in medicine
IT8820073A0 (it) Formulazioni farmaceutiche acquose di piroxicam e procedimento per laloro preparazione.
DK0416950T3 (da) Medikamenter
ITMI913170A1 (it) Composizione farmaceutica per uso oftalmico contenente un antiinfiammatorio non steroideo ed un decongestionante come principi attivi
IT1217445B (it) Composizione farmaceutiche orosolubili contenti acetilcisteina
HRP20010684B1 (hr) Izravno stlaciva matrica za kontrolirano otpustanje jednostruke dnevne doze klaritromicina
DE3774415D1 (de) Pharmazeutische zusammensetzung fuer die prophylaxe und die therapie des magengeschwuers.
HUT47233A (en) Process for producing pharmaceutical comprising phenol derivatives as active ingredient and for producing the active ingredients
DE3869088D1 (de) Pharmazeutische zusammensetzungen.
EP0271151A3 (en) Azumolene dosage form
ATA124091A (de) Pharmazeutische präparation enthaltend eine thrombolytisch wirkende substanz
ES512748A0 (es) "procedimiento para la preparacion de comprimidos a base del antibiotico fosfomicina".
DE3764233D1 (de) Cyclopentylaether, deren herstellung und pharmazeutische formulierung.

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19960628

MM4A Annulment/lapse due to non-payment of fees, searched and examined patent

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20061228